Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: Follow-up results of a randomized study

Journal of Invasive Cardiology

Volumn 13, Issue 6, 2001, Pages 431-436

  Machraoui, Abderrahman ^a,c   Germing, Alfried ^b   Lindstaedt, Michael ^b   Von Dryander, Stefan ^b   Bojara, Waldemar ^b   Lawo, Thomas ^b   Lemke, Bernd ^b   Jaeger, Detlev ^b   Grewe, Peter ^b   Deneke, Thomas ^b   Barmeyer, Juergen ^b  

^a Diakonissenkrankenhaus ^*  (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Diakonissenkrankenhaus   (Germany)

Author keywords

Monotherapy; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STENT; TREATMENT OUTCOME;

AGED; ASPIRIN; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0035377221     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706.
2. Haude M, Erbel R, Straub U, et al. Short and long term results after intracoronary stenting in human coronary arteries: Monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J 1991;66:337-345.
3. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324:13-17.
4. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
5. Nath FC, Muller DW, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-627.
6. Herrmann HC, Buchbinder M, Clemen MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-819.
7. Kiemeneij F, Laarman GJ, van der Wieken R, Suwarganda J. Emergency coronary stenting with the Palmaz-Schatz stent for failed transluminal coronary angioplasty: Results of a learning phase. Am Heart J 1993;126:23-31.
8. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
9. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group. N Engl J Med 1994;331:489-495.
10. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of BENESTENT trial. BENESTENT Study Group. J Am Coll Cardiol 1996;27:255-261.
11. Pepine CJ, Holmes DR Jr. Coronary artery stents. J Am Coll Cardiol 1996;28:782-794.
12. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.
13. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 1998;98:1597-1603.
14. More RS, Chauhan A. Antiplatelet rather than anticoagulant therapy with coronary stenting. Lancet 1997;349:146-147.
15. Machraoui A, Germing A, von Dryander S, et al. High pressure coronary stenting: Efficacy and safety of aspirin versus coumadin plus aspirin. J Invas Cardiol 1997;9:171-176.
16. Schömig A, Neumann FJ, Walter H, et al. Coronary stent placement in patients with acute myocardial infarction: Comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997;29:28-34.
17. Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). Circulation 1998;98:2126-2132.
18. Albiero R, Hall P, Itoh A, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997;95:1145-1156.
19. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-222.
20. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
21. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1665-1671.
22. Park SW, Park SJ, Hong MK, et al. Coronary stenting (Cordis) without anticoagulation. Am J Cardiol 1997;79:901-904.
23. Barragan P, Sainsous J, Silvestri M, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994;32:133-138.
24. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation 1996;94:1519-1527.
25. Lablanche JM, McFadden EP, Bonnet JL, et al. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J 1996;17:1373-1380.
26. Van Belle E, McFadden EP, Lablanche JM, et al. Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: An alternative therapeutic strategy after bailout stent implantation. Coron Artery Dis 1995;6:341-345.
27. Elsner M, Peifer A, Drexler M, et al. Clinical outcome at six months of coronary stenting followed by ticlopidine monotherapy. Am J Cardiol 1998;81:147-151.
28. Serruys PW, Foley DP, de Feyter PJ. Quantitative coronary angiography in clinical practice. Dordrecht: Kluwer Academics, 1994.
29. Barragan P, Sainsous J, Silvestri M, et al. Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: Prospective study of 1,051 consecutive patients. Cathet Cardiovasc Diagn 1997;42:367-373.
30. Moussa I, Di Mario C, Reimers B, et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
31. Berger PB, Bell MR, Grill DE, et al. Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin). Am J Cardiol 1998;81:713-718.
32. Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291-1298.
33. Oesterle SN, Whitbourn R, Fitzgerald PJ, et al. The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J 1998;136:578-599.
34. Colombo A, Di Mario C, Reimers B, et al. Coronary stenting in 1,000 consecutive patients. Long-term clinical and angiographic results. G Ital Cardiol 1997;27:19-31.
35. Kastrati A, Schuhlen H, Hausleiter J, et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: Six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation 1997;96:462-467.
36. Cattaneo M, Akkawat B, Lecchi A, et al. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate. Thromb Haemost 1991;66:694-699.
37. May AE, Neumann FJ, Gawaz M, et al. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur Heart J 1997;18:1913-1920.
38. Gawaz M, Neumann FJ, Ott I, et al. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation 1996;94:279-285.
39. Neumann FJ, Gawaz M, Dickfeld T, et al. Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol 1997;29:1515-1519.
40. Hass WK, Easton JD, Adams HPJ, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989;321:501-507.
41. Malony BA. An analysis of the side effects of ticlopidine. In: Hass WK, Easton JD (eds). Ticlopidine, Platelets and Vascular Disease. New York: Springer, 1993.
42. Berglund U, Lindahl T. Enhanced onset of platelet inhibition with a loading dose of ticlopidine in ASA-treated stable coronary patients. Int J Cardiol 1998;64:215-217.
43. van de Loo A, Nauck M, Noory E, et al. Enhancement of platelet inhibition of ticlopidine plus aspirin vs. aspirin alone given prior to elective PTCA. Eur Heart J 1998;19:96-102.
44. Mishkel GJ, Aguirre FV, Ligon RW, et al. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 1999;34:1884-1890.
45. Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-2366.
46. Kolansky DM, Klugherz BD, Curran SC, et al. Combination therapy with clopidogrel and aspirin after coronary stenting. Cathet Cardiovasc Intervent 2000;50:276-279.